Susquehanna International Group, LLP Morpho Sys Ag Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$17.36 - $19.34 $2.71 Million - $3.02 Million
-156,000 Reduced 86.86%
23,600 $429,000
Q1 2024

May 07, 2024
BUY
$8.6 - $18.18 $42,140 - $89,082
4,900 Added 2.8%
179,600 $3.26 Million
Q4 2023

Feb 14, 2024
BUY
$4.55 - $9.9 $794,885 - $1.73 Million
174,700 New
174,700 $1.73 Million

Others Institutions Holding MOR

# of Institutions
13
Shares Held
1.8M
Call Options Held
0
Put Options Held
14.7K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email